Staging: The extent of the cancer is determined by tumor size, whether cancer cells have spread to nearby lymph nodes, and whether additional metastatic events have occurred. Note:Annual screening with low-dose computed tomography (LDCT) is recommended in current smokers with a 30 pack per year...
Lung cancer is the most prevalent cancer worldwide, and histopathological assessment is indispensable for its diagnosis. However, human evaluation of pathology slides cannot accurately predict patients’ prognoses. In this study, we obtain 2,186 haematoxylin and eosin stained histopathology whole-slide im...
Small cell lung cancer (SCLC) patients exhibit significant heterogeneity in tumor burden, physical condition, and responses to initial treatment. This diversity in treatment responses can result in varying treatment outcomes. The primary objective of this study was to explore the patient demographics ass...
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med. 2015;3(4):282–9. Article PubMed PubMed Central Google Scholar Alsharif M, Andrade ...
Some forms of advanced lung disease, including COPD and IPF, are associated with increased risk for lung cancer, a complication that can arise in the native lung after transplantation [76, 142]. Patients also often have structural damage to the native lung from their underlying disease process,...
Travis, W. D. Pathology of lung cancer.Clin Chest Med32, 669–692,https://doi.org/10.1016/j.ccm.2011.08.005(2011). ArticlePubMedGoogle Scholar Ing, N.et al. InInformation Technologies in Medicine: 5th International Conference,ITIB 2016 Kamień Śląski,Poland,June 20–22,2016 Proceedings...
Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer. Clin. Transl. Oncol. 2007, 9, 32–39. [Google Scholar] [CrossRef] [PubMed] Spanhol, F.A.; Oliveira, L.; Cavalin, P.R.; Petitjean...
Moreover, 5% of patients with metastatic kidney cancer and 28% of those with metastatic NSCLC may harbor metastatic occult brain disease [99,100,101,102,103,104]. These data once again underline the importance of whole-body imaging staging. Regarding the morphological features and ...